Chemical protein synthesis

Current Opinion in Biotechnology

Volumn 9, Issue 4, 1998, Pages 412-426

  Wilken, Jill ^a   Kent, Stephen B H ^a  

^a Gryphon Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PROTEIN; WATER;

CHEMISTRY; GENOME; PH; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0032146861     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80016-5     Document Type: Article

References (89)

1. Frisch C, Schreiber G, Johnson CM, Fersht AR. Thermodynamics of the interaction of barnase and barstar: changes in free energy versus changes in enthalpy on mutation. J Mol Biol. 267:1997;696-706.
2. Winter G, Fersht AR, Wilkinson AJ, Zoller M, Smith M. Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding. Nature. 299:1982;756-758.
3. Fisher E. Untersuchungen uber aminosauren, polypeptide, und proteine. Ber Chem Ges. 39:1906;530-610.
4. Seiber P, Kamber B, Hartmann A, Riniker B, Rittel W. Total synthese von human insulin unter gezielter bildung der dislfidbindungen. Helv Chem Acta. 57:1974;2617-2621.
5. Sakakibara S. Synthesis of large peptides in solution. Biopolymers (Pept Sci). 37:1995;17-28.
6. Inui T, Bodi J, Kubo S, Hishio H, Kimura T, Kojima S, Maruta H, Muramatsu T, Sakakibara S. Solution synthesis of human midkine, a novel heparin-binding neurotrophic factor consisting of 121 amino acid residues with five disulphide bonds. J Pept Sci. 2:1996;28-39.
7. Kojima S, Inui T, Muramatsu H, Suzuki Y, Kadomatsu K, Yoshizawa M, Hirose S, Kimura T, Sakakibara S, Muramatsu T. Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem. 272:1997;9410-9416.
8. Merrifield RB. Solid phase peptide synthesis. Science. 232:1986;341-347.
9. Schneider J, Kent SBH. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease. Cell. 54:1988;363-368.
10. Wlodawer A, Miller M, Jaskolski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SBH. Crystal structure of synthetic HIV-1 protease: conserved fold in retroviral proteases. Science. 245:1989;616-621.
11. Miller M, Sathyanarayana BK, Toth MV, Marshall GR, Clawson L, Selk L, Schneider J, Kent SBH, Wlodawer. Structure of a complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution. Science. 246:1989;1149-1152.
12. Miller M, Geller M, Gribskov M, Kent SBH. Analysis of the structure of chemically synthesized HIV-1 protease complexed with a hexapeptide inhibitor. Part I: crystallographic refinement of 2.0 Angstrom data. Proteins - Struct Funct Genet. 27:1997;184-194.
13. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 338:1998;853-860.
14. Jackson DY, Burnier J, Quan C, Stanley M, Tom J, Wells JA. A designed peptides ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science. 266:1994;243-247.
15. Witte K, Sears P, Martin R, Wong C-H. Enzymatic glycoprotein synthesis: preparation of ribonuclease glycoforms via enzymatic glycopeptide condensation and glycosylation. J Am Chem Soc. 119:1997;2114-2118.
16. Tatusov RL, Koonin EV, Lipman DJ. A genomic perspective on protein families. Genome Issue: Building Gene Families. Science. 278:1997;631-637.
17. Clark-Lewis I, Vo L, Owen P, Anderson J. Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol. 287:1997;233-250.
18. Rajarathnam K, Kay CM, Clark-Lewis I, Sykes BD. Characterization of quaternary structure of interleukin-8 and functional implications. Methods Enzymol. 287:1997;89-105.
19. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. Neutrophil activation by monomeric interleukin 8. Science. 264:1994;90-92.
20. Schnölzer M, Kent SBH. Constructing proteins by dovetailing unprotected synthetic peptides: backbone engineered HIV protease. Science. 256:1992;221-225.
21. deLisle Milton R, Milton S, Schnölzer M, Kent SBH. Synthesis of proteins by chemical ligation of unprotected peptide segments: mirror-image enzyme molecules, D- & L-HIV protease analogues. Angeletti R. Techniques in Protein Chemistry. 1993;257-267 Academic Press, New York.
22. Schnölzer M, Alewood P, Alewood D, Kent SBH. "In situ" neutralization protocols in Boc-chemistry solid phase peptide synthesis: rapid, high yield assembly of difficult sequences. Int J Pept Protein Res. 40:1992;180-193.
23. Baca M, Muir TW, Schnölzer M, Kent SBH. Chemical ligation of cysteine-containing peptides: synthesis of a 22kDa tethered dimer of HIV-1 protease. J Am Chem Soc. 117:1995;1881-1887.
24. Williams M, Muir TW, Ginsberg M, Kent SBH. Total chemical synthesis of a folded β-sandwich protein domain: a fibronectin type 3 module. J Am Chem Soc. 116:1994;10797-10798.
25. Miller M, Baca M, Rao JKM, Kent SBH. Probing the structural basis of the catalytic activity of HIV-1 protease through total chemical protein synthesis. J Mol Struct. 423:1998;137-152.
26. Canne LE, Ferré-D'Amaré AR, Burley SK, Kent SBH. Total chemical synthesis of a unique transcription factor-related protein: cMyc-Max. J Am Chem Soc. 117:1995;2998-3007.
27. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH. Synthesis of proteins by native chemical ligation. Science. 266:1994;776-779.
28. Hackeng TM, Mounier CM, Bon C, Dawson PE, Griffin JH, Kent SBH. Total chemical synthesis of enzymatically active human type II secretory phospholipase A2. Proc Natl Acad Sci USA. 94:1997;7845-7850.
29. Dawson PE, Churchill M, Ghadiri MR, Kent SBH. Modulation of reactivity in native chemical ligation through the use of thiol additives. J Am Chem Soc. 119:1997;4325-4329.
30. Muir TW, Dawson PE, Kent SBH. Protein synthesis by chemical ligation of unprotected peptide segments in aqueous solution. Fields GB. Methods in Enzymology: Solid Phase Peptide Synthesis. 289:1997;266-298 Academic Press, New York.
31. Ueda H, Siani MA, Gong W, Thompson DA, Brown GG, Wang JM. Chemically synthesized SDF-1 analogue, N33A, is a potent chemotactic agent for CXCR4/Fusin/LESTR-expressing human leukocytes. J Biol Chem. 272:1997;24966-24960.
32. Anfinsen CB. Principles that govern the folding of protein chains. Science. 181:1973;223-230.
33. Todd MJ, Viitanen PV, Lorimer GH. Dynamics of the chaperonin ATPase cycle: implications for facilitated protein folding. Science. 265:1994;659-666.
34. Mitraki A, King J. Protein folding intermediaries and inclusion body formation. Biotechnology. 7:1989;690-697.
35. Jaenicke R, Rudolph R. Folding proteins. Creighton TE. Protein Structure: A Practical Approach. 1989;191-223 IRL Press, Oxford University Press, Oxford.
36. Fersht A. Cited in "Folded me deadly'. Nat Struct Biol. 5:1998;327-328.
37. Lu W, Qasim MA, Kent SBH. Comparative total synthesis of turkey ovomucoid third domain by both stepwise solid phase peptide synthesis and native chemical ligation. J Am Chem Soc. 118:1996;8518-8523.
38. Chait BT, Kent SBH. Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins. Science. 257:1992;1885-1894.
39. Schnölzer M, Jones A, Alewood PF, Kent SBH. Ionspray mass spectrometry in peptide synthesis: structural characterization of minor by-products in the synthesis of ACP(65-74). Anal Biochem. 204:1992;335-343.
40. Fitzgerald MC, Kent SBH. Total chemical synthesis of proteins. Hecht SM. Bioorganic Chemistry: Peptides and Proteins. 1998;65-99 Oxford University Press, New York.
41. Lu W, Starovasnik MA, Kent SBH. Total chemical synthesis of bovine pancreatic trypsin inhibitor by native chemical ligation. FEBS Lett. 429:1998;31-35.
42. Muir TW, Williams M, Kent SBH. Detection of synthetic protein isomers & conformers by electrospray mass spectrometry. Anal Biochem. 224:1995;100-109.
43. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16:1997;6996-7007.
44. Dealwis C, Fernandez EJ, Thompson DA, Simon RJ, Siani MA, Lolis E. Crystal structure of chemically synthesized [N33A]SDF-1α, a potent ligand for the HIV-1 'Fusin' co-receptor. Proc Natl Acad Sci USA. 95:1998;6941-6946.
45. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legier DF, et al. The CXC chemokines SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
46. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
47. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 15:1997;675-705.
48. Campbell JJ, Hendrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science. 279:1998;381-384.
49. Offord RE. Going beyond the code. Protein Eng. 7:1991;709-710.
50. Hohsaka T, Ashizuka Y, Murakami H, Sisido M. Incorporation of nonnatural amino acids into streptavidin through in vitro frameshift suppression. J Am Chem Soc. 118:1996;9778-9779.
51. Baca M, Alewood PF, Kent SBH. Structural engineering of HIV-1 protease with a β-turn mimic of fixed geometry. Protein Sci. 2:1993;1085-1091.
52. Phelan JC, Skelton NJ, Braisted A, McDowell RS. A general method for constraining short peptides to an α-helical conformation. J Am Chem Soc. 119:1997;455-460.
53. Love SG, Muir TW, Ramage R, Shaw KT, Alexeev D, Sawyer L, Kelly SM, Price NC, Arnold JE, Mee MP, Mayer RJ. Synthetic, structural and biological studies of the ubiquitin system: synthesis and crystal structure of an analog containing unnatural amino acids. Biochem J. 323:1997;727-734.
54. Baca M, Kent SBH. Catalytic contribution of flap-substrate hydrogen bonds in HIV-1 protease explored by chemical synthesis. Proc Natl Acad Sci USA. 90:1993;11638-11642.
55. Lu W, Qasim MA, Laskowski M Jr, Kent SBH. Probing intermolecular main chain H-bonding in serine proteinase - protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain. Biochemistry. 36:1997;673-679.
56. Nielsen KJ, Alewood D, Andrews J, Kent SBH, Craik DJ. 1H NMR determination of the three dimensional structures of mirror image forms of a Leu5 variant of the trypsin inhibitor Ecballium elaterium (EETI-II). Protein Sci. 3:1994;291-302.
57. Zawadzke LE, Berg JM. The structure of a centrosymmetric protein crystal. Proteins. 16:1993;301-305.
58. Schumacher TNM, Mayr LM, Minor DL Jr, Milhollen MA, Burgess MW, Kim PS. Identification of D-peptide ligands through mirror-image phase display. Science. 271:1996;1854-1857.
59. Hung L-W, Kohmura M, Ariyoshi Y, Kim S-H. Crystallization and preliminary X-ray analysis of D-monellin. Acta Crystallogr Sect D Biol Crystallogr. 53:1997;327-328.
60. Zhao Y, Kent SBH, Chait BT. Rapid, sensitive structure analysis of oligosaccharides. Proc Natl Acad Sci USA. 94:1997;1629-1633.
61. Winans KA, King DS, Bertozzi CR. Synthesis and structural characterization of an antibacterial glycoprotein. CARB-066 in Book of Abstracts, 214th ACS National Meeting. 1997 September 7-11.
62. Rodriguez EC, Winans KA, King DS, Bertozzi CR. A strategy for the chemoselective synthesis of O-linked glycopeptides with native sugar-peptide linkages. J Am Chem Soc. 119:1997;9905-9906.
63. Yarema KJ, Bertozzi C. Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr Opin Chem Biol. 2:1998;49-61.
64. Camarero JA, Pavel J, TW Muir. Chemical synthesis of a circular protein domain: evidence for folding-assisted cyclization. Int Ed Angew Chem. 37:1998;347-349.
65. Zhang L, Tam JP. Synthesis and application of unprotected cyclic peptides as building blocks for peptides dendrimers. J Am Chem Soc. 119:1997;2363-2370.
66. Camarero JA, Muir TW. Chemoselective backbone cyclization of unprotected peptides. Chem Commun. 1997;1369-1370.
67. Rose K. Facile synthesis of homogeneous artificial proteins. J Am Chem Soc. 116:1994;30-33.
68. Dawson PE, Kent SBH. Convenient total synthesis of a 4-Helix TASP molecule by chemoselective ligation. J Am Chem Soc. 115:1993;7263-7266.
69. Rau HK, Haehnel W. Design, synthesis, and properties of a novel Cytochrome b model. J Am Chem Soc. 120:1998;468-476.
70. Wong AK, Jacobsen MP, Winzor DJ, Fairlie DP. Template assembled synthetic proteins (TASPs): are template size, shape, and directionality important in formation of four-helix bundles? J Am Chem Soc. 120:1998;3836-3841.
71. DeGrado WF. Protein design enhanced: proteins from scratch. Science. 278:1997;80-81.
72. Dalal S, Balasubramanian S, Reagan L. Protein alchemy: changing the beta sheet into alpha helix. Nat Struct Biol. 4:1997;548-552.
73. Coldren CD, Hellinga HW, Caradonna JP. The rational design and construction of a cuboidal iron-sulfur protein. Proc Natl Acad Sci USA. 94:1997;6635-6640.
74. Dahiyat BI, Mayo SL. De novo protein design: fully automated sequence selection. Science. 278:1997;82-87.
75. Klostermeier D, Bayer P, Kraft M, Frank RW, Roesch P. Spectroscopic investigations of HIV-1 trans-activator and related peptides in aqueous solutions. Biophys Chem. 63:1997;87-96.
76. Stenberg Y, Julenius K, Dahlqvist I, Drakenberg T, Stenflo J. Calcium-binding properties of the third and fourth epidermal-growth-factor-like modules in vitamin-K-dependent protein. Eur J Biochem. 248:1997;63-170.
77. De Rocquigny H, Petitjean P, Tanchou V, Decimo D, Drouot L, Delaunay T, Darlix J-L, Roques BP. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem. 272:1997;30753-30759.
78. Kuhlman B, Boice JA, Fairman R, Raleigh DP. Structure and stability of the N-terminal domain of the ribosomal protein L9: evidence for rapid two-state folding. Biochemistry. 37:1998;1025-1032.
79. De Laureto PP, Scaramella E, De Filippis V, Marin O, Doni MG, Fontana A. Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation. Protein Sci. 7:1998;433-444.
80. Johansson JS, Gibney BR, Skalicky JJ, Wand AJ, Dutton PL. A native-like three-helix bundle protein from structure-based redesign: a novel maquette scaffold. J Am Chem Soc. 120:1998;3881-3886.
81. Canne LE, Simon RJ, Kent SBH. Solid phase protein synthesis by chemical ligation of unprotected peptides in aqueous solution. Tam JP. Proceedings of the American Peptide Symposium. 1997; Nashville. 1998;ESCOM. in press.
82. Berman AL, Kolker E, Trifonov EN. Underlying order in protein sequence organization. Proc Natl Acad Sci USA. 91:1994;4044-4047.
83. Muir TW, Sondhi D, Cole PA. Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci USA. 1998.
84. Severinov K, Muir TW. Expressed protein ligation: a novel method for studying protein-protein interactions in transcription. J Biol Chem. 1998;. in press.
85. Erlanson DA, Chytil M, Verdine GL. The leucine zipper domain controls the orientation of AP-1 in the NFAT·AP-1·DNA complex. Chem Biol. 3:1996;981-991.
86. Muir TW, Dawson PE, Fitzgerald MC, Kent SBH. Probing the chemical basis of binding activity in an SH3 domain by protein signature analysis. Chem Biol. 3:1996;817-825.
87. Dawson PE, Fitzgerald MC, Muir TW, Kent SBH. Methods for the chemical synthesis and readout of self-encoded arrays of polypeptide analogues. J Am Chem Soc. 119:1997;7917-7927.
88. Wallin E, von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 7:1998;1029-1038.
89. Muir TW, Williams MJ, Ginsberg MH, Kent SBH. Design and chemical synthesis of a neoprotein structural model for the cytoplasmic domain of a multisubunit cell-surface receptor: integrin allbb3 (platelet GPIIb-IIIa). Biochemistry. 33:1994;7701-7708.